Delivery Order SPE2DB20D3103-SPE2DB24FL9V7
Award Date 12/19/23
Potential Completion Date 12/20/23
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $12,264.35 firm fixed-price delivery order is for the pharmaceutical product Dupixent 300 mg/2 ml pen, with a final completion date of February 8, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,957.03 firm-fixed-price delivery order is for the pharmaceutical product Dupixent 300 mg/2 ml pen with an ultimate completion date of April 25, 2023. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $5,395.15 firm-fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pen, a specialty medication, to support military healthcare programs. The award has an ultimate completion date of January 12, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $13,395.44 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pens to support military healthcare programs. The contract has an ultimate completion date of January 30, 2024. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $15,840.96 firm-fixed-price delivery order is for the pharmaceutical product Dupixent 300 mg/2 ml pen (2 ml). The award has no set-aside designation, indicating it was competed openly. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $16,221.01 firm fixed-price delivery order is for the pharmaceutical product Dupixent 300 mg/2 ml pen, with a completion date of April 3, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $59,298.24, is a delivery order for the provision of Dupixent 300 mg/2 ml pen, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of April 24, 2025. The award is not associated with a set-aside program, indicating open competition. Amerisourcebergen Drug...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $37,839.86 firm-fixed-price delivery order is for the medication Dupixent 300 mg/2 ml pen. The award is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle for the company to supply a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,324.58 firm fixed-price delivery order, awarded on December 17, 2024, is for the supply of Dupixent 300 mg/2 ml pen, a specialty pharmaceutical product, with a completion date of December 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $10,721.75, is a delivery order for the pharmaceutical product Dupixent 300 mg/2 ml pen with an ultimate completion date of January 26, 2024. The contract is a firm fixed-price arrangement, and there was no set-aside designation used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a...